BPI Labs
503B outsourcing facility in Largo, Florida. Named publicly by . What is checkable, and how to check it.
Updated 2026-09-18
If your vial comes from BPI Labs, the thing that matters most to you day to day is not the company name on the box — it is the concentration printed on the label.
No provider we review names this pharmacy publicly. It appears here because it is widely reported as supplying compounded GLP-1s and because it has a published FDA record worth being able to look up — you may well be dispensed from it without ever being told.
What the pharmacy decides about your injection
Compounded preparations are not standardised. The pharmacy sets the concentration, which is what turns your prescribed dose in milligrams into the volume you actually draw. Change pharmacy and that number can change, which means the same prescription becomes a different marking on the syringe. It also sets the beyond-use date, which is usually far shorter than a manufacturer expiry. Both of those land on you at the kitchen table, not in a boardroom.
Our read
BPI’s record is inspection observations and registration correspondence with no warning letter, which is a relatively settled shape for a facility inspected as often as a 503B is. The more pressing question for a patient is continuity rather than quality: if FDA finalises its April 2026 proposal to strike semaglutide and tirzepatide from the 503B Bulks List, facilities like this one lose the route they use to produce at volume. Ask your provider what happens to your supply if their 503B partner stops compounding these drugs — that is a live scenario this year, not a hypothetical.
Who dispenses from it
No provider in our roster names this pharmacy publicly, so we cannot tell you who uses it. That is the normal situation in this market and it is the reason these pages exist — ask your provider directly which pharmacy fills your prescription, and check the answer against the FDA list below.
Being named by a provider does not mean that provider uses it exclusively, or that it will fill your particular prescription. Multi-pharmacy networks route by state and by product, so confirm which pharmacy serves you specifically.
FDA enforcement record
FDA publishes inspections, recalls and other actions for compounders. The entry below is quoted from that list as FDA states it. Read the glossary before drawing conclusions — most of these documents are not what people assume.
Listed as: BPI Labs, LLC, Largo, FL — 503B Facility
- 483 Issued 04/17/2026
- FMD-145 Letter Issued 07/28/2025
- 483 Issued 02/21/2025
- FMD-145 Letter Issued 09/01/2021
- 483 Issued 04/30/2021
Our note. No warning letter appears in the published record for this facility.
Worth knowing. How to read this fairly. A Form 483 records inspection observations, not proven violations, and a busy facility that FDA visits often will collect more of them than one nobody inspects. Absence from the list is not a clean bill of health — it can simply mean no inspection or no published action. And the legal entity matters: similarly-named companies are frequently different facilities with different records.
What each document type actually means is explained once on the pharmacies index. Source: FDA, checked 2026-09-18.
The step-by-step way to check a pharmacy licence yourself — state boards, PCAB, NABP and what to ask for — is set out once on the pharmacies index rather than repeated on every page.
Common questions
Can I buy from BPI Labs directly?
No. A compounding pharmacy dispenses against a prescription from a licensed clinician — it is not a shop. Anyone offering to sell you a compounded GLP-1 without a prescription is not operating legally, whatever pharmacy name is attached.
Does a named pharmacy mean the medication is FDA-approved?
No, and this is the distinction that matters most. A compounded preparation is not FDA-approved regardless of how well-regarded the pharmacy is. The pharmacy is licensed and may be accredited; the preparation itself has not been reviewed by the FDA for safety, effectiveness or manufacturing quality.
What is 503A, briefly?
A 503A pharmacy compounds for an individual patient against a specific prescription and is regulated primarily by state boards of pharmacy. A 503B outsourcing facility can produce larger batches, registers with the FDA and is subject to FDA inspection. Full explanation in is compounded GLP-1 still legal.
So when a refill arrives, check the concentration against your last vial before you draw anything. If your provider has quietly switched pharmacy, that is where you will find out.
Verified 2026-09-18 from published sources. We are not affiliated with BPI Labs and this is not an endorsement of any particular pharmacy — it is a record of what is publicly checkable.
Read next
- The pharmacies behind the prescriptions
The pharmacy is the part that is actually regulated — and most providers will not name theirs. Here are the ones that have been named publicly.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- Coreage Rx tirzepatide review
Best overall on true monthly cost. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $199 a month.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure